Delta-8 Tetrahydrocannabinol Product Impurities

Delta-8 Tetrahydrocannabinol Product Impurities

Due to increased concerns regarding unidentified impurities in delta-8 tetrahydrocannabinol (Δ-8 THC) consumer products, a study using Nuclear Magnetic Resonance (NMR), high performance liquid chromatography (HPLC), and mass spectrometry (MS) was conducted to further investigate these products. Ten...

Full description

Bibliographic Details
Main Authors:	Colleen L. Ray, Madison P. Bylo, Jonny Pescaglia, James A. Gawenis, C. Michael Greenlief
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Molecules
Subjects:	NMR tetrahydrocannabinol cannabis hemp cannabidiol product safety
Online Access:	https://www.mdpi.com/1420-3049/27/20/6924

Similar Items

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01)

Applications of <i>Cannabis Sativa</i> L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement
by: Amna Iftikhar, et al.
Published: (2021-12-01)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? [version 6; peer review: 2 approved, 1 approved with reservations]
by: Stephanie Habel, et al.
Published: (2023-05-01)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? [version 5; peer review: 2 approved, 1 approved with reservations]
by: Stephanie Habel, et al.
Published: (2022-11-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
by: Qianru Rao, et al.
Published: (2022-11-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
by: Diana E. Sepulveda, et al.
Published: (2022-10-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

The Desert Whale: the boom and bust of hemp in Arizona
by: Anastasia K. Stats, et al.
Published: (2023-06-01)

Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content
by: CHAOWALIT MONTON, et al.
Published: (2019-10-01)

Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
by: Simon TA, et al.
Published: (2023-01-01)

Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
by: Timo Woelfl, et al.
Published: (2020-11-01)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
by: Paul T. Kocis, et al.
Published: (2020-07-01)

The Challenge of Risk Assessment of Tetrahydrocannabinol (THC) in Cannabidiol (CBD) Oils and Food Supplements: An Approach for Deriving Maximum Limits
by: Sandra Schweikle, et al.
Published: (2022-07-01)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa
by: Wiwit Suttithumsatid, et al.
Published: (2022-01-01)

Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder
by: Tobias Romeyke, et al.
Published: (2022-11-01)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)

Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
by: Adi Gabarin, et al.
Published: (2023-11-01)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01)

Detection of Vegetable Oil Adulteration in Pre-Grated Bovine Hard Cheeses via <sup>1</sup>H NMR Spectroscopy
by: Colleen L. Ray, et al.
Published: (2023-01-01)

A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
by: Matthew Murphy, et al.
Published: (2024-03-01)

Bridging Disciplines: Applications of Forensic Science and Industrial Hemp
by: Sheree J. Finley, et al.
Published: (2022-04-01)

An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
by: Simon Erridge, et al.
Published: (2023-12-01)

Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry
by: Claire Wang, et al.
Published: (2023-07-01)

Effect of harvest time on the compositional changes in essential oils, cannabinoids, and waxes of hemp (Cannabis sativa L.)
by: Pakin Noppawan, et al.
Published: (2022-06-01)

Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01)

Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products
by: Hannah Dräger, et al.
Published: (2022-02-01)

Tolerability and Efficacy of a 10:25 Preparation of Δ9-Tetrahydrocannabinol and Cannabidiol for Treatment of Chronic Back or Neck Pain: A Multiple-Dose Escalation Study
by: Paul Glare, et al.
Published: (2023-07-01)

Ghana’s preparedness to exploit the medicinal value of industrial hemp
by: Richard Quansah Amissah
Published: (2022-11-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020-09-01)

The current state and future perspectives of cannabinoids in cancer biology
by: Paweł Śledziński, et al.
Published: (2018-03-01)

The Anti-Inflammatory Effects of <i>Cannabis sativa</i> Extracts on LPS-Induced Cytokines Release in Human Macrophages
by: Mariia Zaiachuk, et al.
Published: (2023-06-01)

A Proteomic View of Cellular and Molecular Effects of Cannabis
by: Morteza Abyadeh, et al.
Published: (2021-09-01)

Understanding feeling “high” and its role in medical cannabis patient outcomes
by: Sarah S. Stith, et al.
Published: (2023-05-01)

A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain
by: E Gutierre, et al.
Published: (2023-05-01)

Cannabis Effects on Driving Performance: Clinical Considerations
by: Brianna Costales, et al.
Published: (2023-01-01)

Priority areas for cannabis and cannabinoid product research in South Africa
by: Tanya N. Augustine, et al.
Published: (2018-06-01)

Role of Planting Date on Yield and Cannabinoid Content of Day-neutral and Photoperiod-sensitive Hemp in Georgia, USA
by: Timothy Coolong, et al.
Published: (2023-01-01)

Tetrahydrocannabinol in Pediatrics: Room for Improvement?
by: Charlotte De Gier, et al.
Published: (2023-10-01)

Cannabinoids—Characteristics and Potential for Use in Food Production
by: Joanna Kanabus, et al.
Published: (2021-11-01)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
by: Francesco Bartoli, et al.
Published: (2021-03-01)